JINS HOLDINGS Inc. (TYO:3046)
10,190
+90 (0.89%)
Sep 12, 2025, 3:30 PM JST
JINS HOLDINGS Revenue
JINS HOLDINGS had revenue of 24.98B JPY in the quarter ending May 31, 2025, with 18.15% growth. This brings the company's revenue in the last twelve months to 93.65B, up 18.75% year-over-year. In the fiscal year ending August 31, 2024, JINS HOLDINGS had annual revenue of 83.00B with 13.29% growth.
Revenue (ttm)
93.65B
Revenue Growth
+18.75%
P/S Ratio
2.54
Revenue / Employee
26.87M
Employees
3,485
Market Cap
237.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2024 | 83.00B | 9.74B | 13.29% |
Aug 31, 2023 | 73.26B | 6.36B | 9.51% |
Aug 31, 2022 | 66.90B | 3.00B | 4.70% |
Aug 31, 2021 | 63.90B | 3.64B | 6.04% |
Aug 31, 2020 | 60.26B | -1.64B | -2.64% |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
HOYA Corporation | 876.09B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |